ADA: Drug Misses Type 1 Goal, but May Help Beta Cells – MedPage Today

Posted by on Jun 28th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

ADA: Drug Misses Type 1 Goal, but May Help Beta Cells – MedPage Today


CBC.ca

ADA: Drug Misses Type 1 Goal, but May Help Beta Cells
MedPage Today
SAN DIEGO — Although treatment with the monoclonal antibody teplizumab doesn't appear to improve glycemic control or reduce insulin dose among patients with type 1 diabetes, it may still preserve
Life expectancy improves for type 1 diabeticsUSA Today
Erika Rodriguez: The Face of Obesity-Fueled Diabetes at 20ABC News
British researchers develop "cure" for Type 2 diabetes: starve yourselfLos Angeles Times
Reuters –WebMD –AHN | All Headline News
all 215 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.